by Steven F. Pockrass and Alfred B. Robinson Jr., Esqs., Ogletree Deakins
The U.S. Supreme Court in June ruled that pharmaceutical sales representatives are indeed outside salespeople under the terms of the Fair Labor Standards Act () in a case that could have far-reaching effects on other wage-and-hour issues.
The ruling in Christopher v. SmithKline Beecham Corp. (No. 11-204, U.S. Sup. Ct., 2012) means that pharmaceutical sales representatives are exempt from the FLSA’s overtime compensation requirements. Although a critical decision for the pharmaceutical industry, the case is more broadly significant because it provides insight into the weight the Supreme Court would give to agency views of the laws they enforce.
Unusual kinds of ‘sales’
Pharmaceutical companies like SmithKline Beecham promote their drugs to physicians through a process in which sales representatives try to persuade physicians to write prescriptions...(register to read more)
- How to Fire an Employee the Legal Way: 6 Termination Guidelines
- DOL sues to gain access to Forever 21's vendor records
- Settling wage-and-hour case? You'll pay worker's lawyer, too
- House bill would offer employees comp time instead of OT pay
- Make sure rigorous performance expectations don't drive employees to work off the clock